相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease
Jessica A. Starr et al.
ANNALS OF PHARMACOTHERAPY (2022)
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
James B. Wetmore et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy
Jingshi Chen et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)
Executive Summary Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Scott M. Stevens et al.
CHEST (2021)
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
John W. Stanifer et al.
CIRCULATION (2020)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
Joseph H. Schafer et al.
ANNALS OF PHARMACOTHERAPY (2018)
Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study
Frederikus A. Klok et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Safety and effectiveness of apixaban compared to warfarin in dialysis patients
Daniel Reed et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
Thomas A. Mavrakanas et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
A Multicenter Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis
Taylor D. Steuber et al.
ANNALS OF PHARMACOTHERAPY (2017)
Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial
Xianchen Liu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta- analysis
T. van der Hulle et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms
Keattiyoat Wattanakit et al.
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Chronic kidney disease increases risk for venous thromboembolism
Keattiyoat Wattanakit et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
分享论文
